DVA - Javier Rodriguez Implements A Sell Strategy: Offloads $43.36M In DaVita Stock | Benzinga
Javier Rodriguez, Chief Executive Officer at DaVita (NYSE:DVA), disclosed an insider sell on February 28, according to a recent SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Rodriguez sold 345,142 shares of DaVita. The total transaction amounted to $43,363,753.
Monitoring the market, DaVita's shares down by 0.39% at $126.48 during Thursday's morning.
About DaVita
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
DaVita: Financial Performance Dissected
Positive Revenue Trend: Examining DaVita's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 7.85% as of 31 ...